Montanova Capital
Montanova Capital reported 95 stocks worth $4.8B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are MANE (10.8%), ARQT (6.8%) and LEGN (4.3%). Compared with Q1 2026, the fund opened new positions in AVLN, HUT and APH, added to ARQT, AVBP and TSM, trimmed LEGN, PVLA and RCUS and sold out of ERAS, LTH and WING.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  MANE Veradermics Inc | $513M | 10.8% | 4.2M | No change | 2 of 8 | |
| 2 |  ARQT Arcutis Biotherapeutics Inc | $326M | 6.8% | 12.4M | +110K (+1%) | 8 of 8 | |
| 3 |  LEGN Legend Biotech Corp | $204M | 4.3% | 7.1M | −511K (−7%) | 7 of 8 | |
| 4 |  PVLA Palvella Therapeutics Inc NE | $174M | 3.6% | 1.1M | −18K (−2%) | 7 of 8 | |
| 5 |  AVBP Arrivent Biopharma Inc | $157M | 3.3% | 4.5M | +114K (+3%) | 8 of 8 | |
| 6 |  BNTC Benitec Biopharma Inc | $155M | 3.3% | 11.5M | No change | 8 of 8 | |
| 7 |  BHVN Biohaven Ltd | $153M | 3.2% | 10.3M | No change | 8 of 8 | |
| 8 |  AMD Advanced Micro Devices Inc | $149M | 3.1% | 257K | No change | 8 of 8 | |
| 9 |  RCUS Arcus Biosciences Inc | $147M | 3.1% | 4.8M | −255K (−5%) | 8 of 8 | |
| 10 |  TSM Taiwan Semiconductor Mfg Ltd | $145M | 3.1% | 305K | +5,920 (+2%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
APELLIS PHARMACEUTICALS INC | $142M | 3.5M |
KALVISTA PHARMACEUTICALS INC | $96M | 4.8M |
 ERAS Erasca Inc | $55.6M | 3.4M |
 LTH Life Time Group Holdings Inc | $13.7M | 510K |
 WING Wingstop Inc | $9.2M | 60K |
🔒 Free account: see all 14.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 SPY Spdr S&P 500 ETF TR | Put | $709M | 950K | +600,000 |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Montanova Capital 13F FAQ
What does Montanova Capital own?
Montanova Capital reported 95 stocks worth $4.8B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are MANE (10.8%), ARQT (6.8%) and LEGN (4.3%). The table above lists every position in the filing (the top 10 without an account).
What did Montanova Capital buy and sell in Q2 2026?
Compared with Q1 2026: 21 new positions, 25 added to, 17 trimmed and 14 sold out. New positions include AVLN, HUT and APH. It sold all of ERAS, LTH and WING.
When will Montanova Capital file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Montanova Capital's portfolio worth?
The Q2 2026 filing reports $4.8B in US stocks ($5.5B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.